Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women

Cyclin dependent kinase inhibitor 2B (CDKN2B) encodes a cyclin-dependent kinase inhibitor that may enhance the formation of atherosclerotic plaques. The aim of the present study was to investigate the contribution of CDKN2B promoter methylation on the risk of coronary heart disease (CHD). The presen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Exp Ther Med
Main Authors: Chen, Xiaomin, Jiang, Danjie, Xu, Limin, Han, Liyuan, Hu, Haochang, Huang, Yi, Lu, Deyi, Ji, Huihui, Li, Bin, Yang, Yong, Zhou, Cong, Xu, Xuting, Wu, Nan, Xu, Xiaofeng, Xu, Yan, Shen, Yusheng, Li, Jiyi, Duan, Shiwei
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2019
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307461/
https://ncbi.nlm.nih.gov/pubmed/30651784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6920
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki